MFG
REGN icon

Monumental Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Monumental Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-960
Closed -$454K – 110
2021
Q1 		$454K Buy
+960
New +$467K 0.43% 43

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Monumental Financial Group's REGN Position: Q2 2021 in Review

Monumental Financial Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2021, closing a stake of 960 shares — an estimated $454K sold.

Monumental Financial Group first reported a position in REGN in Q1 2021 and held it in 1 quarter. The position peaked at $454K in Q1 2021. 972 funds tracked by Wall St. Rank hold REGN as of Q2 2021.

  • Monumental Financial Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Monumental Financial Group sold 960 Regeneron Pharmaceuticals shares in Q2 2021, an estimated $454K.
  • Monumental Financial Group first reported a position in Regeneron Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Monumental Financial Group's Regeneron Pharmaceuticals position peaked at $454K in Q1 2021.
  • 972 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2021.

Based on Monumental Financial Group's 13F filing for Q2 2021, filed 12 Aug 2021.